Testicular cancer patterns in Tunisian men : Diagnosis problems, pathological types and prognosis. About 41 patients
Keywords:
Testicular, Cancer, Incidence, Epidemiology, Cryptorchidism, Orchiectomy, Mortality, Tunisia.Abstract
Aim: To analyze the testicular cancer (TCa) incidence, diagnosis aspects, pathologic grade, stage, and survival in Tunisian men.Methods: We studied all patients who had histopathologically confirmed TCa treated in La Rabta University-Hospital between 1991 and 2010. Baseline demographic data included age at diagnosis, year of diagnosis, clinical symptoms, stage at diagnosis, histologic type, management strategies and survival were analyzed.
Results: The incidence of TCa among Tunisians is very low; we collected only 41 cases over a period of 20 years with an average incidence of 2 new cases per year. Peak age incidence was 30-49 years. Testicular swelling was the principal complaint in 25 patients. 58.5% of tumours were rightsided and 39% were left-sided. There was bilateral involvement in only one case. The mean interval between onset of symptoms and presentation was 16.5 months (1-120). Most patients presented at stages T2 and T3 (63.4% and 26.8% respectively). Treatment consisted of radical orchidectomy in all patients and cisplatin-based chemotherapy and radiotherapy in respectively 11 and 12 patients (association in 5 patients). One patient with a tumour in an intra-abdominal testis underwent laparotomy. The most common histological types were seminomas (n=20) and mixed germ cell (n=8). Three patients died within 48 months, while half were lost to follow-up.
Conclusions: The incidence of TCas in Tunisia remains low. Late presentation and treatment are major challenges to management. Better health funding and education regarding testicular selfexamination is essential.
Downloads
References
Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
Ries L, Kosary CL, Hankey BF, et al. SEER Cancer Statistics Review, 1975-2000. Bethesda, National Cancer Institute, 2003.
Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents. Lyon: IARC Cancerbase, 2005.
Curado MP, Edwards B, Shin Her et al. Cancer incidence in five continents. Lyon: IARC Scientific Publications, 2007.
Albers P, Albrecht W, Algaba F, et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol. 2011;60:304-19.
Eble JN, Sauter G, Epstein JI, Sesterhenn I. WHO Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004.
Salako AA, Onakpoya UU, Osasan SA, Omoniyi-Esan GO. Testicular and para-testicular tumors in south western Nigeria. Afr Health Sci. 2010;10:14-7.
Møller H. Trends in incidence of testicular cancer and prostate cancer in Denmark. Hum Reprod. 2001;16:1007-11.
Power DA, Brown RS, Brock CS, Payne HA, Majeed A, Babb P. Trends in testicular carcinoma in England and Wales, 1971- 99. BJU Int. 2001;87:361-5.
Houlgatte A. Diagnostic et principe de traitement d'un cancer du testicule. Prog Urol. 2009;19:241-3.
Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med. 1997;337:242-53.
Gajendran VK, Nguyen M, Ellison LM. Testicular cancer patterns in African-American men. Urology. 2005;66:602-5.
Mottet N. Epidémiologie du cancer du testicule. Prog Urol. 2003;13:1243.
Obafunwa JO, Elesha SO, Odunjo EO. Testicular morphometric studies in Nigerian males. Afr J Med Med Sci. 1993;22:39-44.
Junaid TA. Tumours of the testis in Ibadan, Nigeria. Br J Urol. 1982;54:411-4.
Ben Abdallah M, Zehani S, Hizem Ben Ayoub W. Registre des cancers Nord-Tunisie Données 1999-2003 Evolution 1994- 2003 Projections à l'horizon 2024. Iriscom, 2009: 30.
Bray F, Klint A, Gislum M, et al. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol. 2010;49:644-54.
Bergström R, Adami HO, Möhner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst. 1996;88:727-33.
Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol. 2003;170:5-11.
Rosen A, Jayram G, Drazer M, Eggener SE. Global trends in testicular cancer incidence and mortality. Eur Urol. 2011;60:374-9.
Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer. 2005;115:822-7.
Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA. International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev. 2010;19:1151-9.
Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. Prenatal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer. 2000;87:438-43.
Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer. 2005;116:331-9.
Pinczowski D, McLaughlin JK, Läckgren G, Adami HO, Persson I. Occurrence of testicular cancer in patients operated on for cryptorchidism and inguinal hernia. J Urol. 1991;146:1291-4.
Boyle P, Zaridze DG. Risk factors for prostate and testicular cancer. Eur J Cancer. 1993;29:1048-55.
No authors listed. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. United Kingdom Testicular Cancer Study Group. BMJ. 1994;308:1393-9.
Møller H, Skakkebaek NE. Risks of testicular cancer and cryptorchidism in relation to socio-economic status and related factors: case-control studies in Denmark. Int J Cancer. 1996 3;66:287-93.
Dieckmann KP, Loy V, Buttner P. Prevalence of bilateral germ cell tumors and early detection based on contralateral testicular intra-epithelial neoplasia. Br J Urol. 1993;71:340-5.
Dieckmann KP, Pichlmeier U. The prevalence of familial testicular cancer. Cancer. 1997;80:1954-60.
Moller H, Prener A, Skakkebaek NE. Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy and genital malformations: case-control studies in Denmark. Cancer Causes Control. 1996;7:264-74.
Weestergaard T, Olsen JH, Frisch M, Kroman N, Nielsen JW, Melbye M. Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population based study. Int J Cancer. 1996;66:627-31.
Myrup C, Wohlfahrt J, Oudin A, Schnack T, Melbye M. Risk of testicular cancer according to birthplace and birth cohort in Denmark. Int J Cancer. 2010;126:217-23.
Germa-Lluch JR, Garcia del Muro X, Maroto P, et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol. 2002;42:553-62.
Skakkebaek EN. Possible carcinoma-in-situ of the testis. Lancet. 1972; ii:516-7.
Richie JP. Neoplasms of the testis. In; Campbell's Urology. 7th ed. Walsh PC, ends, Philadelphia: WB Saunders, 1997: 2411-52.
Wanderas EH, Tretli S, Fossa SD. Trends in incidence of testicular cancer in Norway 1955-1992. Eur J cancer. 1995;31A:2044-8.
Doherty FJ. Ultrasound of the non acute scrotum. In; Raymond HW eds, Seminars in Ultrasound, CT and MRI. New York: WB Saunders, 1991:131-56.
Thurnher S, Hricak H, Carroll PR, Pobiel RS, Filly RA. Imaging the testis. Comparison between MR imaging and US. Radiology. 1988;167:631-6.
Mattrey RF. Magnetic resonance imaging of the scrotum. Semin Ultrasound CT MR. 1991;12:95-108.
Rholl KS, Lee JKT, Ling D, Heiken JP, Glazer HS. MR imaging of the scrotum with a high-resolution surface coil. Radiology. 1987;163:99-103.
Johnson HO, Mattrey RF, Phillipson J. Differentiation of seminomatous from nonseminomatous testicular tumors by MRI. Am J Roentgenol. 1990;154:539-43.
Klein EA. Tumor markers in testis cancer. Urol Clin North Am. 1993;20:67-73.
Peyret C. Tumeurs du testicule. Synthèse et recommandations en onco-urologie. Prog Urol. 1993;2:60-4.
Moul JW, Paulson DF, Dodge RK, Walther PJ. Delay in diagnosis and survival in testicular cancer: impact of effective therapy and changes during 18 years. J Urol. 1990;143:520-3.
Ondrusova M, Ondrus D. Epidemiology and treatment delay in testicular cancer patients: a retrospective study. Int Urol Nephrol. 2008;40:143-8.
Huyghe E, Muller A, Mieusset R, et al. Impact of diagnostic delay in testis cancer: results of a large population-based study. Eur Urol. 2007;52:1710-6.
Abbou C, Bennis F, Ecstein E. Comment je traite un cancer du testicule? Prog Urol. 1996;6:57-63.
Heidenreich A, Höltl W, Albrecht W, Pont J, Engelmann UH. Testis-preserving surgery in bilateral testicular germ cell tumours. Br J Urol. 1997;79:253-7.
Weissbach L. Organ preserving surgery of malignant germ cell tumors. J Urol. 1995;153:90-3.
Ugwumba FO, Aghaji AE. Testicular cancer: Management challenges in an African developing country. S Afr Med J. 2010;100:452-5.
Cortessis V. Epidemiologic insights into the occurrence and causes of testicular cancer. In; Raghavan D ed, Germ cell tumors. BC Decker Inc London, 2003: 16-29.
Bridges PJ, Sharifi R, Razzaq A, Guinan P. Decreased survival of black Americans with testicular cancer. J Urol. 1998;159:1221-3.
Moul JW, Schanne FJ, Thompson IM, et al. Testicular cancer in blacks. A multicenter experience. Cancer. 1994;73:388-93.
Read G, Stenning SP, Cullen MH, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol. 1992;10:1762-8.